Records 1-30 (of 104 Records) |
Query Trace: (precision medicine) or (precision public health)[original query] |
---|
Next-generation sequencing of host genetics risk factors associated with COVID-19 severity and long-COVID in Colombian population. Angulo-Aguado Mariana, et al. Scientific reports 2024 0 0. (1) 8497 |
Nationwide Genomic Surveillance and Response to COVID-19: The VA SeqFORCE and SeqCURE Consortiums. Jay Krishnan et al. Fed Pract 2024 4 (11 Suppl 5) S44-S47 |
Identification and Prediction of Clinical Phenotypes in Hospitalized COVID-19 Patients: A Step towards Precision Medicine. Velez Tom, et al. JMIR formative research 2023 0 0. |
How are genetics, lifestyles, and cardiovascular and thromboembolic events associated following COVID-19 diagnosis? TS Lomte, News Medical, August 2023
A recent study published in Nature Communications evaluated the associations between host genetics, lifestyle factors, and cardiovascular and thromboembolic events (CVEs) after coronavirus disease 2019 (COVID-19). Although prophylactic coagulation is recommended for hospitalized COVID-19 patients, mixed evidence exists for milder ambulatory and more critical COVID-19 patients. Polygenic risk scores (PRSs) have been proposed for early risk stratification and precision medicine. Whether genetic susceptibility to chronic CVD predisposes COVID-19 patients to CVE complications is unknown.
|
Semantic and Population Analysis of the Genetic Targets Related to COVID-19 and Its Association with Genes and Diseases. Papageorgiou Louis, et al. Advances in experimental medicine and biology 2023 0 0. 59-78 |
A retrospective cohort analysis leveraging augmented intelligence to characterize long COVID in the electronic health record: A precision medicine framework. Strasser Zachary H, et al. PLOS digital health 2023 0 0. (7) e0000301 |
Restoring Trust: The Need for Precision Medicine in Infectious Diseases, Public Health and Vaccines. Equils Ozlem, et al. Human vaccines & immunotherapeutics 2023 0 0. 2234787 |
Precision Medicine for More Oxygen (P4O2)—Study Design and First Results of the Long COVID-19 Extension N Baalbaki et al, JPM, June 2023
The Precision Medicine for more Oxygen (P4O2) consortium COVID-19 extension aims to identify long COVID patients that are at risk for developing chronic lung disease and furthermore, to identify treatable traits and innovative personalized therapeutic strategies for prevention and treatment. This study aims to describe the study design and first results of the P4O2 COVID-19 cohort.
|
A deep learning predictive model for public health concerns and hesitancy toward the COVID-19 vaccines. Farghaly Heba Mamdouh, et al. Scientific reports 2023 0 0. (1) 9171 |
Rough-set based learning: Assessing patterns and predictability of anxiety, depression, and sleep scores associated with the use of cannabinoid-based medicine during COVID-19. Ramanna Sheela, et al. Frontiers in artificial intelligence 2023 0 0. 981953 |
Precision management of post-COVID pain: An evidence and clinical-based approach. Fernández-de-Las-Peñas César, et al. European journal of pain (London, England) 2023 0 0. |
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation. Pagani Lisa, et al. International journal of molecular sciences 2023 0 0. (4) |
Application of phylodynamic tools to inform the public health response to COVID-19: a qualitative analysis of expert opinions. Shannan Nicole Rich et al. JMIR formative research 2023 2 |
Precision public-health intervention for care coordination: a real-world study. Andrade Andre Q, et al. The British journal of general practice : the journal of the Royal College of General Practitioners 2023 0 0. (728) e220-e230 |
Factors associated with resistance to SARS-CoV-2 infection discovered using large-scale medical record data and machine learning. Yang Kai-Wen K, et al. PloS one 2023 0 0. (2) e0278466 |
A digital health platform to manage COVID-19: decentralizing technology to empower rural and remote jurisdictions. Katapally Tarun, et al. Rural and remote health 2023 0 0. (1) 8097 |
Towards precision medicine: Omics approach for COVID-19. Cen Xiaoping, et al. Biosafety and health 2023 0 0. |
Use of Artificial Intelligence in the Search for New Information Through Routine Laboratory Tests: Systematic Review. Cardozo Glauco, et al. JMIR bioinformatics and biotechnology 2023 0 0. (1) e40473 |
Rapid and Sensitive Genotyping of SARS-CoV-2 Key Mutation L452R with an RPA-PfAgo Method. Zhao Chenjie, et al. Analytical chemistry 2022 0 0. |
Genomic analysis of SARS-CoV-2 variants of concern circulating in Hawai'i to facilitate public-health policies. Maison David P, et al. PloS one 2022 0 0. (12) e0278287 |
COMBATdb: a database for the COVID-19 Multi-Omics Blood ATlas. Wang Dapeng, et al. Nucleic acids research 2022 0 0. |
Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection. Arriaga-Canon Cristian, et al. International journal of molecular sciences 2022 0 0. (19) |
Intelligent risk prediction in public health using wearable device data MM Raza et al, NPJ Digital Medicine, October 13, 2022
A recent study found that machine learning can predict the risk of COVID-19 infection, by combining biometric data from wearable devices like Fitbit, with electronic symptom surveys. In doing so, they aim to increase the efficiency of test allocation when tracking disease spread in resource-limited settings. But the implications of technology that applies data from wearables stretch far beyond infection monitoring into healthcare delivery and research. The adoption and implementation of this type of technology will depend on regulation, impact on patient outcomes, and cost savings.
|
Human genetic basis of severe or critical illness in COVID-19. Ji Xiao-Shan, et al. Frontiers in cellular and infection microbiology 2022 0 0. 963239 |
The Lancet Summit: Big data and AI in pandemic preparedness October 27-28, 2022, online
Managing COVID-19 and infectious disease is a global priority over the next few decades. Clinical and research communities are committed to reviewing the global response to the COVID-19 pandemic and a key part has been the unprecedented use and rapid scale of technology. This conference will allow diverse stakeholders to discuss opportunities for new pandemic warning systems based on modelling approaches using AI; advances in real-world surveillance and tracking of disease spread; AI for drug screening and rapid diagnostics; and advances in remote treatment and telehealth.
|
Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning. Zucco Adrian G, et al. Scientific reports 2022 0 0. (1) 13879 |
Host/genetic factors associated with COVID-19 call for precision medicine. Thierry Alain R, et al. Precision clinical medicine 2022 0 0. (3) 228-234 |
Multi-Level Biological Network Analysis and Drug Repurposing Based on Leukocyte Transcriptomics in Severe COVID-19: In Silico Systems Biology to Precision Medicine. Sagulkoo Pakorn, et al. Journal of personalized medicine 2022 0 0. (7) |
Genomic Analysis of SARS-CoV-2 Variants of Concern Circulating in Hawai'i to Facilitate Public-Health Policies. Maison David P, et al. Research square 2022 0 0. |
Host Genomics and COVID-19: Implications for Clinical and Public Health Practice CDC Precision Public Health Webinar, October 6, 2022
This seminar will review our emerging knowledge of the role of host genomic factors in the susceptibility and outcomes of COVID-19 infection, response to vaccines and treatments as well as long-term sequels of the disease. Our speakers will discuss implications of such knowledge for clinical and public health practice and how this information could be used in the control of the pandemic, and more generally in the control of infectious diseases.
|
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 03, 2024
- Content source: